Skip to content
Sharism- Lifestyle
Author:
Rznomics
Rznomics Receives Positive Opinion for Orphan Medicinal Product Designation of RZ-001 for Glioma
September 30, 2026
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
September 7, 2026
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
August 29, 2026
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026
June 15, 2026